Transcarent
Summary active Updated Jul 23, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
Transcarent is a Palo Alto-headquartered consumer-directed health and care platform for self-insured employers, hatched by Glen Tullman and Lee Shapiro of 7wireVentures alongside Hemant Taneja of General Catalyst — the same team behind Livongo 123. The company launched publicly in March 2021 after closing its Series A financing in October 2020, which was announced concurrently with the acquisition of BridgeHealth to serve as the foundation of the platform 123. Transcarent achieved unicorn status in 2022 and reached a $2.2 billion valuation with its 2024 Series D 45.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2020-10-22 | Series A | $40M | General Catalyst (Hemant Taneja), 7wireVentures (Lee Shapiro) | Alta Partners, Jove Equity Partners 123 |
| 2021-06-10 | Series B | $58M | General Catalyst, 7wireVentures | Kleiner Perkins, Merck Global Health Innovation Fund, Leaps by Bayer, GreatPoint Ventures, Threshold Ventures, Alta Partners, Jove Equity Partners 6 |
| 2024-05-02 | Series D | $126M | — | — 45 |
What Investors Say
Hemant Taneja, Managing Partner at General Catalyst: “We believe Transcarent will be another game changer…offering their employees a transformative experience across their most common and most important care needs” 1.
What Founders Say
No independently sourced founder testimonials found beyond company press.
Sources
-
Transcarent, “Glen Tullman Joins Transcarent as Chief Executive Officer,” March 18, 2021. Accessed July 23, 2026. https://transcarent.com/press-releases/glen-tullman-joins-transcarent-as-chief-executive-officer↩↩↩↩
-
Forbes, “‘Concierge Medicine On Steroids’ Startup Raised $40 Million To Disrupt Employer-Sponsored Care,” March 18, 2021. Accessed July 23, 2026. https://www.forbes.com/sites/katiejennings/2021/03/18/concierge-medicine-on-steroids-startup-raised-40-million-to-disrupt-primary-care/↩↩↩
-
Vator News, “Transcarent raises $58M to put patients in control of their own health,” June 10, 2021. Accessed July 23, 2026. https://vator.tv/2021-06-10-transcarent-raises-58m-to-put-patients-in-control-of-their-own-health/↩↩↩
-
STAT News, “Transcarent, Glen Tullman’s health tech unicorn, raises $126 million,” May 2, 2024. Accessed July 23, 2026. https://www.statnews.com/2024/05/02/glen-tullman-transcarent-health-tech-secures-126-million-investment/↩↩↩
-
Transcarent, “Transcarent Raises $126 Million Series D,” May 2, 2024. Accessed July 23, 2026. https://transcarent.com/press-releases/transcarent-raises-usd126-million-series-d↩↩↩
-
BusinessWire, “Transcarent Raises $58 Million in Series B Funding,” June 10, 2021. Accessed July 23, 2026. https://www.businesswire.com/news/home/20210610005315/en/Transcarent-Raises-$58-Million-in-Series-B-Funding-to-Accelerate-Consumer-Directed-Health-and-Care-Experience-for-Self-Insured-Employers↩